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Abstract
Background: The incidence of cerebral venous thrombosis (CVT) is low, and in particular, isolated cortical vein
thrombosis (ICVT) is very rare. The diagnosis of ICVT is difficult by using conventional computed tomography (CT)
and magnetic resonance imaging (MRI). However, with appropriate treatment, ICVT has a good prognosis.
Case presentation: Herein, we present a rare case of a 40-year-old woman with ICVT and type II protein S (PS)
deficiency, who experienced a stroke. She initially presented with generalized convulsions. A CT scan showed
intracerebral hemorrhage (ICH) in the left temporoparietal region. However, her condition rapidly deteriorated and
she went into a coma approximately 20 h after admission. A second CT scan revealed significant ICH expansion and
transfalcine herniation. Decompressive hemicraniectomy with duraplasty was performed, and ICVT was confirmed
owing to abnormal vascular tone and black appearance of the cortical vein. She underwent anticoagulation therapy
and rehabilitation, and gradually recovered.
Conclusion: We experienced an extremely rare case of isolated cortical vein thrombosis related with type II PS
deficiency. CT-digital subtraction angiography is a useful supportive technique in the diagnosis of ICVT. Decompressive
hemicraniectomy is effective for hemorrhage extension cases, and ICVT with hemorrhage might require early
anticoagulation therapy.
Keywords: Pregnancy, Type II protein S deficiency, Isolated cortical vein thrombosis, Computed tomography
venography, Magnetic resonance venography
Background
Cerebral venous thrombosis (CVT) is a relatively rare
cause of stroke, and it has been reported to cause
0.5–1.0 % of all strokes [1, 2]. The International
Study on Cerebral Venous and Dural Sinuses Throm-
bosis (ISCVT) reported that approximately 17 % of
stroke cases involved cortical vein occlusions [3]. CVT
without occlusion of the major dural venous sinuses or
deep cerebral veins is termed isolated cortical vein
thrombosis (ICVT) [4]. Headache is less common in
ICVT (71 %) than in major sinus thrombosis (89 %) [5].
Papilledema has not been reported previously. Paren-
chymal brain lesions have been found to be more
common in ICVT cases than in sinus thrombosis cases
(81 % vs. 63 %) [3]. For diagnosis, magnetic resonance
imaging (MRI) is the most frequently used method.
However, in some cases, it is difficult to detect a lesion
on conventional MRI, and in these cases, angiography
is necessary. Anticoagulation therapy appears to be the
standard therapy in patients with ICVT without
hemorrhage. However, it is controversial whether antic-
oagulation therapy should be used in ICVT cases with
intracerebral hemorrhage (ICH). When ICH extends
and impending herniation occurs very infrequently,
decompressive cranioctomy should be performed; how-
ever, this is not the standard therapy [6]. If CVT with-
out ICH is diagnosed in the early stage and appropriate
therapy is administered, the prognosis is excellent, and
this applies to ICVT. Here, we present an extremely
rare case of a patient with ICVT and type II Protein S
(PS) deficiency, who experienced exacerbation without
anticoagulation therapy.
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Case presentation
A 40-year-old woman was admitted to our hospital
because of generalized convulsions. She delivered her
first child 3 weeks ago and was asymptomatic until the
seizure onset. She had no medical history, including
eclampsia, and no family history of hypercoagulable
states. Her seizures were the generalized type and
stopped spontaneously after 2 minutes. She denied ex-
periencing headache, and no papilledema was noted.
On admission, her blood pressure (BP), heart rate, and
body temperature were 138/88 mmHg, 126 beats/min,
and 37 °C, respectively. Neurological deficits were not
identified. A CT scan revealed ICH in the left temporo-
parietal lobe (Fig. 1a). Considering the age of the patient
and absence of a hypertension history, CT-digital
subtraction angiography (CT-DSA) was performed to
rule out conditions such as an aneurysm, arteriovenous
malformation (AVM), and sinus thrombosis, and no
such conditions were noted. The coagulation profile was
assessed, and blood examinations were performed to
check for connective tissue diseases. No abnormal data
was found, except that the PS activity was low at 37 %
(Table 1). This low level was thought to have resulted
from her recent pregnancy state. Her ICH was treated
with conservative medical therapy in order to maintain
her BP below 120 mmHg. MRI and cerebral angiography
were planned on another day to identify the definite eti-
ology. However, 20 hours after admission, her response
to stimuli suddenly decreased, and she presented with
right hemi-paralysis. She did not experience seizures or
headache at that time. Her conscious level was Glasgow
Coma Scale (GCS) E2V3M5. A CT scan showed ICH
expansion and brain midline shift (Fig. 1b). Therefore,
emergent external decompression with duraplasty was
performed. Intraoperatively, the cortical vein appeared
black and stiff, and the cerebral surface with the occlu-
sive vein was congested (Fig. 2), indicating possible
thrombosis of the cortical vein. After the operation, her
intracranial pressure (ICP) was controlled using glycerols
and deep sedation with propofol. An ICP monitor was
not used. For the ICVT, systemic heparinization was
started. MRI/MRA after the operation showed no right
white matter edema or narrow major vessels, which low-
ered the possibility of a differential diagnosis of posterior
reversible encephalopathy syndrome (PRES). The PS
amount and PS activity were assessed again 10 weeks
after delivery. The PS amount was found to be normal;
however, the PS activity was still below normal (Table 1).
Therefore, she was diagnosed with type II PS deficiency.
On the 35th postoperative day (POD), her brain swelling
Table 1 Protein S (PS) and protein C (PC) values in our patient
After labor Normal
range3 weeks 6 weeks 10 weeks
PC activity (%) 59 100 114 70–150
PS activity (%) 37 35 46 60–127
PS amount (%) N/A 77 97 65–135
Free PS amount (%) N/A 54 86 60–150
N/A not applicable
Fig. 1 a Computed tomography images showing intracerebral hemorrhage in the left temporoparietal lobe, without brain midline shift before
exacerbation. b Computed tomography images showing intracerebral hemorrhage expansion in the temporoparietal lobe and brain midline shift
after exacerbation
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reduced, and cranioplasty was performed. Indocyanine
green (ICG) angiography indicated occlusion of the
cortical vein (Fig. 3). She underwent rehabilitation and
was discharged from the hospital on the 58th POD. On
discharge, her GCS was E4V5M6 and modified Rankin
scale score was 3.
Discussion
CVT is a relatively rare cause of stroke and has been
reported to cause 0.5–1.0 % of all strokes [1, 2]. The in-
cidence of ICVT is much lower than that of CVT. There
are no specific symptoms for CVT. The diagnosis is very
difficult owing to the rarity of the condition and obscur-
ity of symptoms. In the meantime, it is helpful to note a
patient’s background and history. The risk factors that
can be easily identified by history taking include preg-
nancy, puerperium, known connective tissue disease,
known malignancy, contraceptive use, and infections,
such as sinusitis, otitis, and mastoiditis [7, 8]. Young
individuals, especially young women are very vulnerable
to this disease. The ISCVT reported that 78 % of all
CVT cases were aged <50 years and that the incidence
of CVT was 3 times greater in women than in men [3]. If
a young individual, particularly a pregnant or puerperal
woman, presents with new onset stroke-like symptoms
such as headache and seizure, it is important to check
for the presence of the above-mentioned risk factors for
CVT. If CVT is suspected, CT venography (CTV) or
MR venography (MRV) should be performed. However,
ICVT is hard to detect using these conventional modal-
ities because of its small size. A recent report showed
that the T2*/susceptibility-weighted image (SWI) MR
sequence is very effective to detect lesions [9]. In our
case, because we suspected CVT but not ICVT, only
CTV was checked and all major sinuses appeared
patent. If we had checked the SWI, the lesion might
have been detected and early intervention could have
been performed. If the initial CT-DSA is retrospectively
checked thoroughly, suspecting any cortical vein lesion,
contrast material in the culprit cortical vein can be
identified (Fig. 4). This showed that only a CT-DSA
image would be sufficient for the diagnosis of IVCT,
and that MRI (SWI) or angiography may not be
imperative in some cases.
Anticoagulation for CVT prevents expansion of the
thrombus and allows for recanalization of the occlusion
site. This therapy is supported by the guidelines of the
European Federation of Neurological Societies (EFNS).
However, in case of hemorrhage presentations, appropri-
ate therapy is very controversial. It has been reported
that 39–41 % of CVT patients presented with ICH,
hemorrhagic venous infarcts, or isolated subarachnoid
hemorrhage [10]. Anticoagulation therapy might worsen
the condition, and its use is therefore controversial.
Some reports suggest that the prognosis of ICVT is
favorable without anticoagulants [11, 12]. However,
without anticoagulation therapy, our patient’s condition
worsened within 24 h even though the lesion was only
an isolated CVT. This event possibly suggests the
importance of immediate anticoagulation therapy for
not only major sinus occlusions but also ICVT, which
is also asymptomatic or incidental. Additionally, if the
ICH expands despite the use of these therapies and
Fig. 2 An intraoperative image showing a black and stiff cortical
vein and congestion of the cerebral surface with the occlusive vein
Fig. 3 a An intraoperative image showing a thin and shrunken cortical vein. b An indocyanine green (ICG) angiography image showing absence
of blood flow in the cortical vein
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contributes to impaired consciousness, decompressive
hemicranioctomy appears to be appropriate to control
ICP, as in our case [6].
PS is a vitamin K-dependent anticoagulant and its
deficiency is thought to be major risk factor for CVT.
According to the classification system proposed in
Munchen in 1992, PS deficiency is classified as type I
(low total and free antigen, reduced activity), type II
(normal total and free antigen, reduced activity), and
type III (normal total antigen, reduced free antigen and
activity). Our patient was diagnosed with type II PS
deficiency, which is an extremely rare disease. Although
the prevalence of PS deficiency in Japan is estimated to
be more than that in European countries, PS deficiency
has been estimated at less than 0.5 % in the general
European population [13]. Type I and type III PS defi-
ciencies have been reported to account for almost all
cases of PS deficiency [14]. Therefore, type II PS defi-
ciency is considered very rare. When PS is suspected as
a risk factor of CVT in pregnant or puerperal women,
the time at which PS is measured after labor is import-
ant. A previous study reported that the free PS levels
decreased significantly from the first trimester to the
second trimester [15]. Another study reported that the
PS activity in the third trimester reduced to 16–42 %
[16]. The time when PS activity returns to normal in the
postpartum period is unclear. However, it is believed
that the PS activity normalizes at approximately 1 month
after delivery. Therefore, as in our case, it is important
to check PS at least 6 weeks after delivery. PS deficiency
can be misdiagnosed as conditions, such as vitamin K
deficiency, liver disease, nephritic syndrome, and dis-
seminated intravascular syndrome. Therefore, these
conditions should also be excluded. We experienced
an extremely rare case of type II PS deficiency, which
contributed to the occurrence of ICVT.
Conclusion
Here, we presented an extremely rare case of a patient
with ICVT and type II PS deficiency, who experienced a
stroke. The patient was successfully treated with external
decompression and anticoagulants. Venous thrombosis
and CVT should be considered in pregnant or puerperal
women who experience stroke. For early diagnosis, it is
vital to suspect CVT, including ICVT, considering the
patient’s background. In such a case, CT-DSA should
be performed and the images should be thoroughly
checked. A hematoma associated with ICVT caused
by a cortical vein might expand without early anticoa-
gulation therapy, as was noted in our case. Therefore,
early anticoagulation therapy might be essential, even
in isolated cases involving ICH.
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Fig. 4 A time delay computed tomography-digital subtraction
angiography image obtained at admission showing the culprit
cortical vein. This vein coincided with the occluded cortical vein
shown in the intraoperative image (Fig. 2)
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